Statements (50)
Predicate | Object |
---|---|
gptkbp:instanceOf |
T cell subtype
|
gptkbp:abundantIn |
gptkb:skin
epithelial tissues gut mucosa |
gptkbp:activatedBy |
phosphoantigens
butyrophilin molecules |
gptkbp:canBe |
regulatory
pro-inflammatory |
gptkbp:canKill |
tumor cells
infected cells |
gptkbp:contributedTo |
innate immunity
adaptive immunity |
gptkbp:developIn |
gptkb:thymus
|
gptkbp:distinctFrom |
alpha beta T cells
|
gptkbp:doNotRequire |
MHC presentation
|
gptkbp:doNotUndergo |
classical positive and negative selection
|
gptkbp:expressedIn |
gptkb:NKG2D
gptkb:CD3 gptkb:TCR_delta_chain gptkb:TCR_gamma_chain NK cell markers gamma delta T cell receptor |
gptkbp:firstDescribed |
1980s
|
gptkbp:foundIn |
vertebrates
|
gptkbp:function |
cytotoxicity
cytokine production immune surveillance |
gptkbp:hasSubgroup |
white blood cells
lymphocytes |
https://www.w3.org/2000/01/rdf-schema#label |
gamma delta T cells
|
gptkbp:involvedIn |
wound healing
tissue homeostasis |
gptkbp:involves |
infectious diseases
autoimmune diseases tumor immunity |
gptkbp:mayExpress |
gptkb:CD4
gptkb:CD8 |
gptkbp:produces |
gptkb:interferon-gamma
gptkb:tumor_necrosis_factor_alpha interleukin-17 |
gptkbp:proportionOfTCells |
1-10% in human peripheral blood
|
gptkbp:recognizedBy |
non-peptide antigens
lipid antigens phosphoantigens |
gptkbp:response |
stress-induced ligands
|
gptkbp:secretes |
gptkb:perforin
gptkb:granzyme_B |
gptkbp:studiedBy |
immunotherapy
|
gptkbp:bfsParent |
gptkb:interleukin-17A
|
gptkbp:bfsLayer |
6
|